Adalimumab plus Conventional Therapy versus Conventional Therapy in Refractory Non-Infectious Scleritis

Long-term systemic glucocorticoids and non-specific immunosuppressants remain the mainstay of treatment for refractory scleritis, and result in serious side-effects and repeated inflammation flares. To assess the efficacy and safety of additional adalimumab, patients diagnosed with refractory non-in...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Binyao, Yang, Shizhao, Zhu, Lei, Peng, Xuening, He, Daquan, Tao, Tianyu, Su, Wenru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697705/
https://www.ncbi.nlm.nih.gov/pubmed/36431163
http://dx.doi.org/10.3390/jcm11226686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697705/
https://www.ncbi.nlm.nih.gov/pubmed/36431163
http://dx.doi.org/10.3390/jcm11226686

Ejemplares similares